COMMUNIQUÉS West-GlobeNewswire

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
26/08/2026
If approved, REVTORPYK would be the first and only therapy for advanced breast cancer with a PIK3CA mutation that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 MINNEAPOLIS, Aug. 26 [...]
NOMAD Power Solutions, Inc. Receives DOE Authorization to Advance Vermont Long-Duration Energy Storage Project into Phase 3
26/08/2026
Installation phase will deploy NOMAD’s transportable battery energy storage technology at sites within Green Mountain Power’s service territory BOCA RATON, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, [...]
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
26/08/2026
Leading oncology experts and company management will discuss the Phase 3 OVATION 3 study, supporting science and data, clinical progress, and upcoming milestones A patient treated with IMNN-001 will share firsthand [...]
Candel Therapeutics to Present at September Investor Conferences
26/08/2026
NEEDHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference
26/08/2026
DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible [...]
SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth
26/08/2026
National nine-city education series expands Hydrafacial's industry-leading provider training platform LONG BEACH, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (NASDAQ: SKIN), home to Hydrafacial, today [...]
Guidelight Health Virtual Brings Evidence-Based Mental Health Care to All of Colorado, Massachusetts and North Carolina
26/08/2026
Expansion means clients no longer need to live near a Guidelight clinic to access the same structured, skills-based care BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Guidelight Health, a leader in evidence-based mental [...]
Tvardi Therapeutics to Participate in Upcoming Investor Events
26/08/2026
HOUSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting [...]
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
26/08/2026
RADNOR, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
26/08/2026
NAARDEN, The Netherlands and MIAMI, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Curonix LLC Appoints Healthcare and Financial Services Veteran Carlos A. Migoya to Board of Managers
26/08/2026
POMPANO BEACH, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the appointment of Carlos A. Migoya to its Board of Managers [...]
CoreHealth Technologies Acquires Konnected to Expand Wellness Expertise and Program Delivery Capabilities
26/08/2026
TORONTO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- CoreHealth Technologies, a leading provider of configurable wellness technology and health assessment solutions, today announced the acquisition of Konnected Workplace Wellness [...]
Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
26/08/2026
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities Blair, Nebraska, Aug. 26, 2026 (GLOBE NEWSWIRE) -- As the U.S. biotechnology sector [...]
HepaRegeniX Receives Orphan Drug Designation for Darizmetinib for the Prevention of Post-Hepatectomy Liver Failure
26/08/2026
U.S. FDA Orphan Drug Designation underscores darizmetinib’s potential to address a significant unmet need following liver resection Tuebingen, Germany, August 26, 2026 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical- [...]
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
26/08/2026
NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with Neurocrine Nxera to [...]
4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
26/08/2026
Commercial collaboration combines 4basebio’s synthetic DNA technology with Genezen’s viral vector development and manufacturing expertise to support gene therapy programs from early development through clinical and [...]
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
26/08/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 26, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Testie Health Launches Nationwide to Make STI Testing Simpler, Faster, and Less Stigmatized
26/08/2026
New York, NY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Testie Health , a consumer health company focused on making routine STI testing easier and less stigmatized, launches nationwide with a direct-to-lab testing model [...]
Celularity Provides Update Regarding Nasdaq Listing Compliance
26/08/2026
FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it received a notification letter from the Listing Qualifications Department [...]

Pages